Urticaria multiforme-like: a COVID-19 infection
Cristiana Canelas Mendes, Rita Pimenta
Corresponding author: Cristiana Canelas Mendes, Department of Internal Medicine 2, Centro Hospitalar Universitário de Lisboa Norte, Hospital de Santa Maria, Lisboa, Portugal
Received: 29 Oct 2020 - Accepted: 17 Nov 2020 - Published: 30 Nov 2020
Domain: Dermatology,Internal medicine
Keywords: COVID-19, cutaneous manifestations, skin
©Cristiana Canelas Mendes et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite this article: Cristiana Canelas Mendes et al. Urticaria multiforme-like: a COVID-19 infection. Pan African Medical Journal. 2020;37:286. [doi: 10.11604/pamj.2020.37.286.26740]
Available online at: https://www.panafrican-med-journal.com//content/article/37/286/full
Urticaria multiforme-like: a COVID-19 infection
Cristiana Canelas Mendes1,&, Rita Pimenta2
&Corresponding author
An 18-year-old, otherwise healthy woman, presented to the emergency department with a three-day history of acute-onset diffuse rash. She denied recent introduction of new drugs or dermocosmetic products and previously adverse drug reactions or allergies. She hadn't had any known contact with anyone with confirmed SARS-CoV-2 infection. On examination, she had a temperature of 38.6°C. Physical examination showed a disseminated, asymptomatic and not evanescent annular erythematous urticarial papules and plaques, some with targetoid appearance, mostly located at the back (A), chest (B), inguinal zone (C), distal portions of upper (D) and lower limbs and forehead. The palmoplantar skin and mucous membranes were spared. Laboratory tests showed d-dimer elevation (0.43 μg/ml, normal range 0.0-0.25 μg/ml). Chest radiography and computed tomographic pulmonary angiography was normal. A reverse-transcriptase-polymerase-chain-reaction test for severe acute respiratory syndrome coronavirus 2, performed on a nasopharyngeal swab, was positive. A diagnosis of COVID-19 infection was made. On the sixth day of follow-up, fevers and rash were disappeared. The particular interest of this case is the inaugural appearance of a cutaneous manifestation, before any other symptom. It is essential to take into account and promote the recognition among clinicians of this possible skin manifestation of COVID-19, because an early diagnosis, could contribute to break the chain of transmission immediately.
Figure 1: urticaria multiforme-like: a COVID-19 infection